NCT00300235

Brief Summary

Priapism, a prolonged erection of the penis, is a medical issue that often affects men with sickle cell disease. The purpose of this study is to collect demographic and clinical information on priapism by interviewing men with sickle cell disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,464

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2005

Typical duration for all trials

Geographic Reach
1 country

27 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 8, 2006

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

August 3, 2009

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

2.6 years

First QC Date

March 7, 2006

Results QC Date

March 13, 2009

Last Update Submit

January 14, 2019

Conditions

Keywords

Sickle Cell Anemia

Outcome Measures

Primary Outcomes (1)

  • Enumeration of the Prevalence of Priapism in Males With Sickle Cell Anemia and Sickle Beta Zero Thalassemia.

    Subject responded YES to survey Question "Have you ever had priapism?". By diagnosis and age group. Enumeration of the prevalence of priapism in males with sickle cell anemia and sickle beta zero thalassemia.

    At time of interview

Secondary Outcomes (3)

  • Characterization of Priapism in Males With Sickle Cell Anemia With Reference to Time of Onset, Duration of Events, Frequency of Episodes, Precipitating or Associated Activities, Treatment Modalities Used, and Outcome of Treatments

    Cross-sectional single survey visit

  • Descriptive Comparison of the Prevalence of Priapism in Males With Sickle Cell Anemia to That Described in Older Patients With Other Sickle Hemoglobinopathies

    Cross-sectional single survey visit

  • Assessment of General Patient and Parent Understanding of Priapism as a Complication of Sickle Cell Disease Gained From Completion of Protocol

    Cross-sectional single survey visit

Study Arms (5)

1

200 subjects ages 5 to 9.9 years with a diagnosis of HbSS/HbSβ0

2

400 subjects ages 10 to 14.9 years with a diagnosis of HbSS/HbSβ0

3

400 subjects ages 15 to 24.9 years with a diagnosis of HbSS/HbSβ0

4

400 subjects over the age of 25 with a diagnosis of HbSS/HbSβ0

5

250 subjects age 15 and older with a diagnosis of HbSC or HbSβ+

Eligibility Criteria

Age5 Years+
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Males receiving care in any Comprehensive Sickle Cell Center.

You may qualify if:

  • Diagnosis of sickle cell anemia or sickle beta zero thalassemia, if 5 years of age or over OR
  • Diagnosis of sickle beta plus thalassemia or sickle hemoglobin C disease, if 15 years of age or over
  • Participant and/or parent or guardian must be able to communicate adequately with the interviewer

You may not qualify if:

  • Subjects who meet any of the following criteria are disqualified from enrollment in the study:
  • Patient or parent/guardian declines participation.
  • Female.
  • Subject or parent/guardian unable to communicate adequately with the interviewer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (27)

University of South Alabama

Mobile, Alabama, 36688-0002, United States

Location

University of California, Davis

Davis, California, 95616, United States

Location

Children's Hospital and Research Center at Oakland & Summit Medical Center

Oakland, California, 94609, United States

Location

Kaiser Permanente, Oakland

Oakland, California, 94611, United States

Location

University of California, San Francisco

San Francisco, California, 94143, United States

Location

University of Colorado Health Sciences Center

Denver, Colorado, 80206, United States

Location

University of Florida

Gainesville, Florida, 32610-0383, United States

Location

Kosair Children's Hospital

Louisville, Kentucky, 40202, United States

Location

Brigham and Women's Hospital at Harvard Medical School

Boston, Massachusetts, 02115, United States

Location

Children's Hospital of Boston

Boston, Massachusetts, 02115, United States

Location

Boston Medical Center

Boston, Massachusetts, 02118, United States

Location

Wayne State University

Detroit, Michigan, 48202, United States

Location

Children's Hospital Montefiore

The Bronx, New York, 10467-2940, United States

Location

Montefiore Medical Center and Children's Hospital at Montefiore

The Bronx, New York, 10467, United States

Location

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

University of Cincinnati Hospital

Cincinnati, Ohio, 45267, United States

Location

Ohio State University

Columbus, Ohio, 43210, United States

Location

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

Location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

St. Christopher's Hospital for Children

Philadelphia, Pennsylvania, 19134, United States

Location

St. Jude Children's Hospital

Memphis, Tennessee, 38105, United States

Location

University of Texas Parkland Health & Hospital System

Dallas, Texas, 75390-8852, United States

Location

University of Texas Children's Medical Center of Dallas

Dallas, Texas, 75390, United States

Location

University of Texas Medical Branch at Galveston

Galveston, Texas, 77555, United States

Location

MeSH Terms

Conditions

PriapismAnemia, Sickle Cell

Condition Hierarchy (Ancestors)

Penile DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Karen Kesler, PhD
Organization
Rho Federal Systems Division

Study Officials

  • Samir Ballas, MD

    Thomas Jefferson University

    STUDY CHAIR
  • Lennette Benjamin

    Montefiore Medical Center and Children's Hospital of Montefiore

    STUDY CHAIR
  • J. Bessman, MD

    University of Texas Southwestern at Galveston

    STUDY CHAIR
  • Joan Cain, MD

    UT Children's Hospital of Oklahoma

    STUDY CHAIR
  • Lewis Hsu, MD

    St. Christopher's Hospital

    STUDY CHAIR
  • Laura DeCastro, MD

    Duke University

    STUDY CHAIR
  • Cage Johnson, MD

    University of Southern California Los Angeles County & University of Southern California Medical Center

    STUDY CHAIR
  • Karen Kalinyak, MD

    Children's Hospital Medical Center, Cincinnati

    STUDY CHAIR
  • Susan Lieff, PhD

    Rho, Inc.

    STUDY CHAIR
  • Lillian McMahon, MD

    Boston Medical Center

    STUDY CHAIR
  • William Mentzer, MD

    University of California San Francisco Pediatric Hematology/Oncology

    STUDY CHAIR
  • Ashok Raj, MD

    Norton Healthcare

    STUDY CHAIR
  • Rupa Redding-Lallinger, MD

    University of North Carolina, Chapel Hill

    STUDY CHAIR
  • Zora R. Rogers, MD

    University of Texas Southwestern Medical Center at Dallas and Children's Medical Center

    STUDY CHAIR
  • Cynthia Rutherford, MD

    University of Texas, Southwestern Medical Center at Dallas

    STUDY CHAIR
  • Kim Smith-Whitley, MD

    Children's Hospital of Philadelphia

    STUDY CHAIR
  • Elliott Vichinsky, MD

    Children's Hospital and Research Center at Oakland & Summit Medical Center

    STUDY CHAIR
  • Winfred Wang, MD

    St. Jude Children's Research Hospital

    STUDY CHAIR
  • Richard Snyder, MD

    University of Cincinnati

    STUDY CHAIR
  • Kathryn Hassell, MD

    University of Colorado, Denver

    STUDY CHAIR
  • Matthew Heeney, MD

    Boston Children's Hospital

    STUDY CHAIR
  • Eric Kraut, MD

    Ohio State University

    STUDY CHAIR
  • Stacy Month, MD

    Kaiser Permanente - Oakland

    STUDY CHAIR
  • Maureen Okam, MD

    Dana-Farber Cancer Institute

    STUDY CHAIR
  • Courtney Thornburg, MD

    Duke University

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

March 7, 2006

First Posted

March 8, 2006

Study Start

August 1, 2005

Primary Completion

March 1, 2008

Study Completion

March 1, 2008

Last Updated

February 1, 2019

Results First Posted

August 3, 2009

Record last verified: 2019-01

Locations